Market Research Logo

Brazil Pharmaceuticals and Healthcare Report Q4 2017

BMI View: The Brazilian pharmaceutical market has markedly declined in recent years in US dollar termsdue to the country's recession, limiting potential returns for drugmakers. Despite the anticipated recoveryin 2017, Brazil will remain a highly challenging market due to price and market access controls.

Headline Expenditure Projections

Pharmaceuticals: BRL73.65bn (USD19.87bn) in 2016 to BRL77.64bn (USD23.89bn) in 2017; +5.4%in local currency terms and +20.2% in US dollar terms. Local currency forecast unchanged fromprevious quarter.

Healthcare: BRL541.77bn (USD155.35bn) in 2016 to BRL585.11bn (USD180.03bn) in 2017; +8.0% inlocal currency terms and +15.9% in US dollar terms. Local currency forecast unchanged from previousquarter.

Latest Updates

The National Sanitary Surveillance Agency (ANVISA) of Brazil is drafting legislation that regulates theminimum requirements for the administration of vaccines in pharmacies which, if passed, will boostcommercial opportunities for vaccine producers.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Brazil 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Brazil 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Brazil 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Brazil 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Brazil 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Brazil 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Brazil 2015-2021)
Industry Risk/Reward Index
Americas Pharmaceuticals: Attractiveness To Drugmakers Masks Disparities Between Markets
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Brazil 2011-2016)
Table: Healthcare Personnel (Brazil 2011-2016)
Table: Healthcare Activity (Brazil 2011-2016)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Top 10 Pharmaceutical Companies In Brazil By Sales, 2013
Table: Multinational Pharmaceutical Company Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Aché/Biosintética
Cristália
EMS Sigma
Eurofarma
GlaxoSmithKline
Medley
Merck & Co
Novartis
Pfizer
Roche
Sanofi
Demographic Forecast
Table: Population Headline Indicators (Brazil 1990-2025)
Table: Key Population Ratios (Brazil 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Brazil 1990-2025)
Table: Population By Age Group (Brazil 1990-2025)
Table: Population By Age Group % (Brazil 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report